Master Protocol to Assess the Safety and Recommended Phase 2 Dose of Next Generation NY-ESO-1-specific TCR T-cells in HLA-A*02 Patients with Synovial Sarcoma and Non-Small Cell Lung Cancer.
CANCER RESEARCH(2021)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要